

Why They’re Not the Same — And Why That Matters for You
If you’ve been told you have “MTHFR,” you may already know there’s more than one variant. However, the differences between C677T and A1298C go far beyond a label. They affect your body through entirely different biochemical pathways, which means symptoms, risk factors, and the most effective support strategies can vary significantly from one person to another.
MTHFR is an enzyme responsible for converting folate into its active, usable form called 5-MTHF. Active folate plays a critical role in helping convert homocysteine—a potentially harmful compound—back into methionine, which supports more than 200 essential processes throughout the body.
Key functions supported by methionine include:
When MTHFR function is reduced, this entire process can be disrupted. The specific effects depend on which genetic variant is present.
C677T causes the MTHFR enzyme to become structurally unstable, reducing its effectiveness at normal body temperature. The impact increases based on the number of copies inherited.
Enzyme activity reduction:
Common downstream effects:
The Riboflavin Connection
Riboflavin (Vitamin B2) serves as a critical cofactor that helps stabilize the MTHFR enzyme. Research has shown that individuals with homozygous C677T may experience meaningful improvements in enzyme function and reductions in homocysteine levels through riboflavin support, sometimes even more effectively than folate supplementation alone.
Unlike C677T, A1298C primarily affects the production of BH4 (tetrahydrobiopterin) rather than folate activation. BH4 is essential for the production of neurotransmitters and nitric oxide.
BH4 supports the production of:
Enzyme activity reduction:
Common downstream effects:
Many practitioners use homocysteine as the primary marker for MTHFR function. However, individuals with A1298C often have normal homocysteine levels despite experiencing significant symptoms.
This is because A1298C primarily affects neurotransmitter production rather than homocysteine metabolism. As a result, normal homocysteine levels do not necessarily indicate normal function.
In some cases, aggressive methylfolate supplementation may worsen symptoms if BH4-related imbalances have not been addressed first.
Individuals who carry one C677T variant and one A1298C variant are considered compound heterozygous.
This combination affects both methylation and neurotransmitter pathways simultaneously, creating a more complex clinical picture.
Estimated combined enzyme reduction:
Common presentations include:
Because both pathways are impacted, compound heterozygous individuals often benefit from a highly individualized and carefully sequenced approach.
Primary impact: Mild reduction in 5-MTHF production
Key marker: Homocysteine
Priority support: Riboflavin and methylfolate
Typical presentation: Often minimal symptoms unless under significant physiological stress
Primary impact: Severe reduction in 5-MTHF production
Key marker: Homocysteine
Priority support: Riboflavin first, followed by methylfolate
Typical presentation: Increased cardiovascular, clotting, and fertility concerns
Primary impact: Mild reduction in BH4 synthesis
Key marker: Neurotransmitter-related symptoms
Priority support: BH4 support and gentle methylfolate use
Typical presentation: Anxiety, mood changes, and cognitive concerns
Primary impact: Moderate reduction in BH4 synthesis
Key marker: Neurotransmitter-related symptoms
Priority support: BH4-focused support while avoiding excessive methylfolate
Typical presentation: Mood instability, anxiety, and dopamine/serotonin imbalances
Primary impact: Both methylation and BH4 pathways affected
Key markers: Homocysteine and neuropsychiatric symptoms
Priority support: Sequential support, often addressing BH4 first
Typical presentation: The most complex clinical picture, requiring a nuanced and personalized strategy
Your MTHFR variant is not a diagnosis. Rather, it provides insight into how your body may process folate, methylation, neurotransmitters, and related biochemical pathways.
Two individuals with the same genetic variant can experience very different symptoms depending on factors such as nutrient status, stress levels, environmental exposures, and overall health.
Because of this, one-size-fits-all MTHFR protocols are rarely effective. In some cases, they may even create new challenges.
The goal is not to “fix” your MTHFR. The goal is to understand your unique methylation profile and create a personalized support plan that works for your body.
Schedule a consultation with Eirene Integrative Wellness to gain a deeper understanding of your unique genetic and biochemical landscape and receive individualized guidance designed specifically for your needs.